BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25911555)

  • 1. Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A.
    Zanolini D; Merlin S; Feola M; Ranaldo G; Amoruso A; Gaidano G; Zaffaroni M; Ferrero A; Brunelleschi S; Valente G; Gupta S; Prat M; Follenzi A
    Haematologica; 2015 Jul; 100(7):881-92. PubMed ID: 25911555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia A.
    Arruda VR
    Haematologica; 2015 Jul; 100(7):849-50. PubMed ID: 26130509
    [No Abstract]   [Full Text] [Related]  

  • 3. Factor VIII can be synthesized in hemophilia A mice liver by bone marrow progenitor cell-derived hepatocytes and sinusoidal endothelial cells.
    Yadav N; Kanjirakkuzhiyil S; Ramakrishnan M; Das TK; Mukhopadhyay A
    Stem Cells Dev; 2012 Jan; 21(1):110-20. PubMed ID: 21480781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of endothelial cells corrects the phenotype in hemophilia A mice.
    Kumaran V; Benten D; Follenzi A; Joseph B; Sarkar R; Gupta S
    J Thromb Haemost; 2005 Sep; 3(9):2022-31. PubMed ID: 16102109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of factor VIII by human liver sinusoidal endothelial cells transplanted in immunodeficient uPA mice.
    Fomin ME; Zhou Y; Beyer AI; Publicover J; Baron JL; Muench MO
    PLoS One; 2013; 8(10):e77255. PubMed ID: 24167566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
    Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
    Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor antigen-primed regulatory T cells permit liver regeneration and phenotype correction in hemophilia A mouse by allogeneic bone marrow stem cells.
    Kochat V; Kanjirakkuzhiyil S; Baligar P; Nagarajan P; Mukhopadhyay A
    Stem Cell Res Ther; 2015 Jul; 6(1):129. PubMed ID: 26152192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An effective ex-vivo approach for inducing endothelial progenitor cells from umbilical cord blood CD34
    Qin M; Guan X; Wang H; Zhang Y; Shen B; Zhang Q; Dai W; Ma Y; Jiang Y
    Stem Cell Res Ther; 2017 Feb; 8(1):25. PubMed ID: 28173870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors.
    Chuah MK; Schiedner G; Thorrez L; Brown B; Johnston M; Gillijns V; Hertel S; Van Rooijen N; Lillicrap D; Collen D; VandenDriessche T; Kochanek S
    Blood; 2003 Mar; 101(5):1734-43. PubMed ID: 12406898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors.
    Matsui H; Shibata M; Brown B; Labelle A; Hegadorn C; Andrews C; Hebbel RP; Galipeau J; Hough C; Lillicrap D
    Stem Cells; 2007 Oct; 25(10):2660-9. PubMed ID: 17615271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of bone marrow transplantation for correcting hemophilia A in mice.
    Follenzi A; Raut S; Merlin S; Sarkar R; Gupta S
    Blood; 2012 Jun; 119(23):5532-42. PubMed ID: 22368271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII.
    Wilcox DA; Shi Q; Nurden P; Haberichter SL; Rosenberg JB; Johnson BD; Nurden AT; White GC; Montgomery RR
    J Thromb Haemost; 2003 Dec; 1(12):2477-89. PubMed ID: 14675082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A.
    Olgasi C; Talmon M; Merlin S; Cucci A; Richaud-Patin Y; Ranaldo G; Colangelo D; Di Scipio F; Berta GN; Borsotti C; Valeri F; Faraldi F; Prat M; Messina M; Schinco P; Lombardo A; Raya A; Follenzi A
    Stem Cell Reports; 2018 Dec; 11(6):1391-1406. PubMed ID: 30416049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.
    Wulf-Goldenberg A; Keil M; Fichtner I; Eckert K
    Tissue Cell; 2012 Apr; 44(2):80-6. PubMed ID: 22197619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells.
    Shi Q; Kuether EL; Chen Y; Schroeder JA; Fahs SA; Montgomery RR
    Blood; 2014 Jan; 123(3):395-403. PubMed ID: 24269957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice.
    Kren BT; Unger GM; Sjeklocha L; Trossen AA; Korman V; Diethelm-Okita BM; Reding MT; Steer CJ
    J Clin Invest; 2009 Jul; 119(7):2086-99. PubMed ID: 19509468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of blood outgrowth endothelial cells for gene therapy for hemophilia A.
    Lin Y; Chang L; Solovey A; Healey JF; Lollar P; Hebbel RP
    Blood; 2002 Jan; 99(2):457-62. PubMed ID: 11781225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
    J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice.
    Follenzi A; Benten D; Novikoff P; Faulkner L; Raut S; Gupta S
    J Clin Invest; 2008 Mar; 118(3):935-45. PubMed ID: 18274668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice.
    Ramezani A; Zweier-Renn LA; Hawley RG
    Thromb Haemost; 2011 Apr; 105(4):676-87. PubMed ID: 21264447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.